跳至主要内容
临床试验/NL-OMON45748
NL-OMON45748已完成不适用

CardioMEMS European Monitoring Study for Heart Failure - MEMS HF

St. Jude Medical0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Indicated to receive a CardioMEMS sensor implant per the CardioMEMS* HF System User*s Manual
  • o > 18 years of age
  • o Diagnosis of NYHA Class III Heart Failure at the time of sensor implantation
  • o Hospitalization for worsening HF within 12 months prior to the CardioMEMS HF System implant. For the purposes of this study, a HF hospitalization is defined as an overnight stay in the hospital with signs and symptoms of congestion requiring intensification of treatment for HF
  • o Subjects with reduced Left Ventricular Ejection Fraction (LVEF) must be on stable Guideline Directed Medical Therapy (GDMT) as tolerated
  • o Written informed consent obtained from subject

排除标准

  • * Known coagulation disorders or inability to take two types of blood thinning medications for one month after the sensor is implanted
  • * Subjects deemed a candidate for transplant, Ventricular Assist Device, or hospice care in the next 12 months or are otherwise not expected to be able to complete the study follow up

研究者

相似试验